NTCell progress: Exciting progress from... - Cure Parkinson's

Cure Parkinson's

25,345 members26,644 posts

NTCell progress

mecklenberger profile image
4 Replies

Exciting progress from NTCell.

8 February 2017 – Sydney, Australia & Auckland, New Zealand – Living Cell Technologies Limited has received approval to commence treating the six patients in group 3 of the Phase IIb clinical trial of NTCELL® for Parkinson’s disease, at Auckland City Hospital.

Four patients will have 120 NTCELL microcapsules implanted into the putamen on each side of their brain, and two patients will have sham surgery with no NTCELL implanted.

The company is blind to the results until 26 weeks after the last patient in group 3 has been treated, at which point the patients who received the placebo may receive the optimal dose of NTCELL.

The Phase IIb trial aims to confirm the most effective dose of NTCELL, define any placebo component of the response and further identify the initial target Parkinson’s disease patient sub-group. If the trial is successful, the company plans to apply for provisional consent to treat paying patients in New Zealand in Q4 2017.

Written by
mecklenberger profile image
mecklenberger
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Hikoi profile image
Hikoi

It is a growrh factor trial isnt it?

jeffreyn profile image
jeffreyn in reply to Hikoi

It certainly has something to do with growth factors.

​"... NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. After transplantation NTCELL functions as a biological factory, producing factors to promote new central nervous system growth and repair disease-induced nerve degeneration."

lctglobal.com/

Go the piggies!

Bazillion profile image
Bazillion

thermh.org.au/news/world-fi...

Missed out on the trial as had AML years ago. The info provided was enough to convince me i would be worth a try. Will be watching with interest!!

You may also like...

Azilect : does it slow progress? Is it neuro protective?

Neuroaspis, 30 months of no progression, and the Science of Parkinson's

Caffeine and progression of Parkinson’s disease: A deleterious interaction with Creatine

treatment for Parkinson’s disease: an updated meta-analysis of randomized controlled trials 2017 -...

First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's

for early-stage Parkinson’s disease, the company announced. The Phase 3 clinical trial...

Is this progression normal